Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 1,401.2 | 1,378.5 | 1,188.9 | 1,093.8 |
| Revenue growth | 1.6% | 15.9% | 8.7% | |
| Cost of goods sold | 936.9 | 937.4 | 869.4 | 861.9 |
| Gross profit | 464.3 | 441.1 | 319.5 | 232.0 |
| Gross margin | 33.1% | 32.0% | 26.9% | 21.2% |
| Sales and marketing | 246.8 | 206.1 | 133.7 | 130.4 |
| Research and development | 129.3 | 117.9 | 99.4 | 84.7 |
| General and administrative | 101.8 | 130.3 | 60.1 | 36.5 |
| EBITA | 49.9 | 9.7 | 28.8 | -16.2 |
| EBITA margin | 3.6% | 0.7% | 2.4% | -1.5% |
| Amortization of intangibles | 63.6 | 23.0 | 2.6 | 3.4 |
| EBIT | -13.7 | -13.3 | 26.2 | -19.6 |
| EBIT margin | -1.0% | -1.0% | 2.2% | -1.8% |
| Pre-tax income | -4.5 | -2.0 | 23.4 | -23.0 |
| Income taxes | 7.5 | 23.0 | 14.9 | 5.0 |
| Tax rate | | | 63.8% | |
| Net income | -12.0 | -36.9 | -14.4 | -49.2 |
| Net margin | -0.9% | -2.7% | -1.2% | -4.5% |
| |
| Diluted EPS | ($0.05) | ($0.26) | ($0.36) | ($1.11) |
| Shares outstanding (diluted) | 254.3 | 142.9 | 40.3 | 44.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|